Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2.
D002648:Child; D002908:Chronic Disease; D004341:Drug Evaluation; D004854:Herpesvirus 4, Human; D006801:Humans; D007244:Infectious Mononucleosis / Q000628:therapy*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins